中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Tragus Stimulation to Prevent Atrial Fibrillation After Cardiac Surgery

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态招聘中
赞助商
University of Chicago
合作者
Parasym Ltd.

关键词

抽象

Patients undergoing cardiac surgery, specifically a coronary artery bypass graft and/or heart valve replacement surgery, are at a higher risk for post-procedure atrial fibrillation (AF). AF is a condition in which the upper chambers of the heart do not contract normally and results in an irregular heartbeat. Recent studies have shown that tragus stimulation decreases the likelihood of AF in animals and humans. It has also been shown to reduce inflammation which may be related to post-procedure AF. Tragus stimulation involves stimulating a part of the outer ear, called the tragus, by sending a microcurrent through a small alligator clip. It is believed that tragus stimulation can affect the nervous system, which may reduce heart rate and lead to prevention of AF. The purpose of this study is to determine whether tragus stimulation in subjects undergoing cardiac surgery will lead to shorter occurrences, or even prevention, of AF.

描述

This is a single-blind study where patients will be randomized tragus stimulation versus sham procedure and remain blinded to their treatment allocation. Both treatment options will utilize similar equipment, namely the use of alligator clips which will be placed on the tragus and earlobe of the right ear for patients. The distinction is only that in patients assigned to tragus stimulation, they will be initiated on therapy at the time of device placement.

Prior to cardiac surgery, the discomfort threshold of both left and righ tragus stimulation will be determined for all participating patients. Intermittent electrode signals, or microcurrents, are delivered at 20 Hz with100 µsec pulse width with variable microampere (mA) output. The discomfort threshold is defined as the stimulation intensity in mA at which point patients experience discomfort. The stimulation intensity used in the study will be set just below the discomfort threshold. The clip will then be placed on the patient's ear at the end of surgery. After surgery is completed, the clip will then be removed and replaced on the opposite ear. Stimulation will then continue, one ear alternating with the other, every 4 hours for a total of 48 hours. It is possible that the threshold can change during the post-operative period. If the patient shows any sign of discomfort from stimulation, the intensity of stimulation will be reduced to a level at which signs of discomfort disappears.

Follow-up will be performed with a 14-day event monitor at the time of discharge. Electrocardiography (ECG) will be performed pre-procedure and prior to hospital discharge. Echocardiography will be assessed prior to study initiation and when clinically available in follow-up.

日期

最后验证: 12/31/2019
首次提交: 01/01/2018
提交的预估入学人数: 01/01/2018
首次发布: 01/07/2018
上次提交的更新: 01/02/2020
最近更新发布: 01/05/2020
实际学习开始日期: 03/08/2018
预计主要完成日期: 06/30/2020
预计完成日期: 06/30/2020

状况或疾病

Atrial Fibrillation

干预/治疗

Device: Stimulation Group

-

手臂组

干预/治疗
No Intervention: Sham Group
At the end of cardiac surgery, the Parasym alligator clip will be placed on the subject's tragus, but the Parasym will not be turned on and the subject will not receive any stimulation. The clip will be switched to the other ear every 4 hours for a total of 48 hours.
Experimental: Stimulation Group
At the end of cardiac surgery, the Parasym alligator clip will be placed on the subject's tragus, and the subject will receive continuous stimulation for 48 hours. The clip will be switched to the other ear every 4 hours.
Device: Stimulation Group
Tragus stimulation will be done using the Parasym device.

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

1. Patients ≥18 years of age, <90 years of age

2. Estimated life expectancy of at least 1 year at the time of enrollment

3. History of sinus rhythm or paroxysmal atrial fibrillation

Exclusion Criteria:

1. Patients ≥90 years of age, <18 years

2. Patients with known prior history of persistent or permanent AF

3. Atrial Fibrillation occurrence within the last 24 hours of procedure

4. Urgent or Emergency cases

5. Pregnant patients

6. Patients undergoing the following cardiac procedures: heart transplant, pulmonary thromboendarterectomy, isolated aortic arch procedures, congenital hear disease, ventricular assist device insertion, extracorporeal membrane oxygenation insertion, and surgical AF ablation

7. Antiarrhythmics prior to surgery (Class I and Class III)

8. High degree atrioventricular block requiring temporary pacing

9. MAZE procedure

结果

主要结果指标

1. Time to the first episode of AF >30 seconds [through study completion, an average of 1 month]

2. Extended hospitalization of >5 days [through study completion, an average of 1 month]

次要成果指标

1. Overall AF burden [through study completion, an average of 1 month]

2. Change in inflammatory markers [baseline and 1 month]

C-reactive protein (ordered if clinically indicated)

3. Actionable AF [through study completion, an average of 1 month]

antiarrhythmic use (including rate-control medications)

4. Actionable AF [through study completion, an average of 1 month]

cardiovascular diseases

5. Actionable AF [through study completion, an average of 1 month]

anticoagulation

6. Actionable AF [through study completion, an average of 1 month]

use of inotropes for BP support during AF

7. Stroke or transient ischemic attack (TIA) [through study completion, an average of 1 month]

8. All-cause mortality [through study completion, an average of 1 month]

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge